Molecules · 2020 · 26 citations · 16 references
MedicineMedicinal ChemistryPharmacologyChemotherapyDrug DesignDrug DiscoveryCellular Drug EffluxChemotherapy ResistanceCytotoxic ChemotherapyMultidrug ResistanceTherapeutic ResistanceAbc TransportersAnticancer ActivityAnticancer ChemotherapyAnticancer Drug ResistanceChemical Structure-activity RelationshipsChemotherapeutic EffluxOvercoming Multidrug ResistanceTransporters
The resistance of tumors against anticancer drugs is a major impediment for chemotherapy. Tumors often develop multidrug resistance as a result of the cellular efflux of chemotherapeutic agents by ABC transporters such as P-glycoprotein (ABCB1/P-gp), Multidrug Resistance Protein 1 (ABCC1/MRP1), or Breast Cancer Resistance Protein (ABCG2/BCRP). By screening a chemolibrary comprising 140 compounds, we identified a set of naturally occurring aurones inducing higher cytotoxicity against P-gp-overexpressing multidrug-resistant (MDR) cells versus sensitive (parental, non-P-gp-overexpressing) cells. Follow-up studies conducted with the P-gp inhibitor tariquidar indicated that the MDR-selective toxicity of azaaurones is not mediated by P-gp. Azaaurone analogs possessing pronounced effects were then designed and synthesized. The knowledge gained from structure-activity relationships will pave the way for the design of a new class of anticancer drugs selectively targeting multidrug-resistant cancer cells.
16
Matthew D. Hall, Noeris K. Salam, Jennifer Hellawell et al. · Journal of Medicinal Chemistry · 2009 · 166 citations · Full text
Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells
Dóra Türk, Matthew D. Hall, Benjamin F. Chu et al. · Cancer Research · 2009 · 108 citations · Full text
Veronika F.S. Pape, Szilárd Tóth, András Füredi et al. · European Journal of Medicinal Chemistry · 2016 · 106 citations